Evidence map›Paper›PMID 36248885›Full record

ArticleFrontiers in immunology2022

Independent value of serum

Liyan Wang, Yanbiao Jiang, Haofei Shen, Xiaoling Ma, Mingxia Gao, Panpan Jin, Rui Zhang, Lihui Zhao, Xuehong Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Liyan WangReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Yanbiao JiangThe First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
Haofei ShenThe First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
Xiaoling MaReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Mingxia GaoReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Panpan JinReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Rui ZhangReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Lihui ZhaoReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Xuehong ZhangReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
First Hospital of Lanzhou University · CNLanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early pregnancy loss (EPL) is the most prevalent complication, particularly in couples undergoing assisted reproductive technology treatment. The present study aimed to determine whether the serum Methods: This was a retrospective cohort study of all couples who received clinical pregnancy and underwent fresh IVF/ICSI cycles at a single large reproductive medical center between January 2013 and June 2020. The research involved a total of 6600 cycles. For risk variables, we conducted the least absolute shrinkage and selection operator (LASSO) analysis, and for risk scoring, we used logistic regression coefficients. To analyze relevant risk factors for EPL, univariate and multivariate logistic regression analyses were employed. Areas under the curve (AUC) were determined and compared between β-hCG and other factors using receiver operating characteristic (ROC) curves. Results: Conclusions: Our results suggest that the serum

Indexed as

Abortion, SpontaneousSperm Injections, IntracytoplasmicChorionic Gonadotropin, beta Subunit, HumanFemaleFertilization in VitroHumansPregnancyRetrospective StudiesChorionic Gonadotropin, beta Subunit, Humanearly pregnancy losshuman chorionic gonadotropinIVF/ICSI cyclepredictionrisk factors

Identifiers

PMID36248885
PMCPMC9556765
OpenAlexW4298005557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.